Deep Longevity Company
Deep Longevity is a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging.
Investors
Technology:
Physiological Biomarkers
Industry:
AI, Data processing, Digital
Headquarters:
Hong Kong, Hong Kong Island, Hong Kong
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
M&A
Investors Number:
7
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-07-14
Last Funding Type:
Series A
Register and Claim Ownership